Evidence map›Paper›PMID 37580251›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Ten-year changes in clinical characteristics and antiviral treatment patterns of chronic hepatitis B in China: a CR-HepB-based real-world study].

X Q Xu, H Wang, S Shan, H You, Y M Nan, X Y Xu, Z P Duan, L Wei, J L Hou, H Zhuang and 3 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
  3. [Recent advances in epidemiology, prevention and treatment of hepatitis B in China].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

X Q XuClinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing 100050, China.
H WangBeijing Clinical Research Institute, Beijing 100050, China.
S ShanLiver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China.
H YouLiver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China.
Y M NanDepartment of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
X Y XuDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
Z P DuanArtificial Liver Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
L WeiDepartment of Hepatology, Beijing Tsinghua Changgung Hospital, Beijing 100044, China.
J L HouDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
H ZhuangDepartment of Microbiology and Parasitology, Peking University Health Science Center, Beijing 100191, China.
J D JiaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China.
Y Y KongClinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing 100050, China.
China Registry of Hepatitis B (CR-HepB) Group
Beijing Friendship Hospital · CNCapital Medical University · CNHebei Medical University · CNNational Clinical Research Center for Digestive Diseases · CNPeking University First Hospital · CNSouthern Medical University · CN

Funding

Beijing Municipal Administration of Hospitals Incubating Program PX2023005High-level Public Health Technical Talents of the Beijing Municipal Health Commission XUEKEGUGAN-010-018
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis AHepatitis BHepatitis B, ChronicAdultAged, 80 and overAntiviral AgentsChinaDNA, ViralFemaleHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansLiver CirrhosisMaleRegistriesAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensChina Registry of Hepatitis BChronic hepatitis BCR-HepBLiver cirrhosisTreatment patterns

Identifiers

PMID37580251
PMCPMC12814509
OpenAlexW4385827756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.